Pharmaceutical Packaging Market Size, Share & Industry Analysis, By Material (Plastics, Glass, Metal, Paper & Paperboard), By Product (Plastic Bottles, Caps & Closures, Pre-Fillable Inhalers, Vials & Ampoules), By Packaging Type (Primary, Secondary, and Tertiary), By Drug Delivery Mode (Oral Drug Delivery Packaging, Injectable Packaging, Topical Drug Delivery Packaging, Pulmonary Drug Delivery Packaging), and Regional Forecast, 2020-2027

This report covers COVID-19 impact analysis on Pharmaceutical Packaging Market

Inquire before buying

The pharmaceutical industry is growing at an unprecedented rate. The requirement of packaging in this industry is mainly dependent on the increase in both communicable and non-communicable diseases and their treatments around the world. Pharmaceutical packaging products are packages that are used to cover, store, protect, and provide information on the packed pharmaceutical preparations. These products are highly regulated as they need to ensure the protection of the medicines from physical damage and external influences that might lead to contamination until the consumption of medicines. This type of packaging also helps in maintaining the stability of the product during its shelf life and is used for product promotions. Further, it also helps manufacturers to differentiate their products from competitors. Rising demand for pharmaceutical drugs and medicines would directly lead to the pharmaceutical packaging market growth.

LATEST TRENDS

Request a sample to learn more about this report.

Development of Novel Drug Packaging Systems to Fuel the Market

The development of the novel drug packaging systems has led to the demand for pharmaceutical packaging. These systems are used to pack prefilled inhalers and prefilled syringes, as these products are meant for single-dose units of the vaccine. These products are seen as replacements for traditional syringes and vials. The prefilled inhalers and syringes are designed in such a way that they protect the packed drugs from directly coming in contact with external surroundings or patients, and thereby avoid its contamination. It also reduces the wastage and provides patient compliance by offering a self-administered metered dosage. A rising aging population coupled with the increasing incidence of diseases such as diabetes and asthma are surging the demand for these products, which will fuel the development of novel drug packaging systems.

DRIVING FACTORS

Rising Pharmaceutical Industry around the Globe to Drive Market Growth

The pharmaceutical industry is growing at a rapid pace mainly in developing economies such as China, India, and Brazil and developed economies such as the US, UK, and Germany. The growth is attributed to the rising population, increasing technological innovations, rise in healthcare awareness, adoption of advanced manufacturing processes, rising spending in public healthcare systems, and implementation of new regulations by governments to control the spread of infectious diseases. Additionally, rising demand for biological products and emerging treatments such as cell and gene therapies are expected to fuel the growth of the pharmaceutical industry, thereby leading to the demand for pharmaceutical packaging products.

Increasing Adoption of Generic Drugs in Developing Countries to Fuel Market Growth

The increasing adoption of generic drugs in developing countries owing to their low costs is expected to fuel the demand for pharmaceutical packaging. A generic drug is a pharmaceutical drug that contains the same chemical ingredients, same dosage, intended use, side effects, and route of administration as the original drug. Many companies are investing in the manufacturing of generic drugs to provide medicinal treatments at lower costs. Packaging plays an important role in the manufacturing process of these drugs as they are needed to efficiently pack and protect drugs during its storage and carriage. Hence, the rising demand for generic drugs will propel the demand for medicinal packaging products.

RESTRAINING FACTORS

Rise in Counterfeit Pharmaceutical Drugs to Restrict Market Growth

Counterfeit pharmaceutical drugs are fake medicines, which may contain false or no active ingredients and can be contaminated. These drugs are illegal and also harmful to health. They are manufactured and sold with the intention to deceptively represent the authenticity, origin, and effectiveness of the original drug. The growth in counterfeit pharmaceuticals is rising due to third shift packaging, where the contract manufacturers seek extra profits by producing additional secret drugs and sell them to the counterfeiters. Hence, rising counterfeit pharmaceutical drugs is anticipated to restrict market growth.

SEGMENTATION

By Material Analysis

Plastics Segment to Remain the Largest Material in the Market

Based on material, this market is segmented into plastics, glass, metal, paper & paperboard, and others. Plastic is the largest raw material used in the production of packaging for pharmaceutical purposes. Plastics such as polyvinyl chloride (PVC), polypropylene (PP), polycarbonate (PC), high impact polystyrene (HIPS), polyethylene terephthalate (PET), and high-density polyethylene (HDPE) are majorly used in this kind of packaging. Plastics are easy to mold in any shape and size, offer protective properties, and are cost-effective and hence, serve as the ideal packaging material for pharmaceutical preparations. These plastics protect drugs from physical damage and contaminations. They find application in bottles, closures, blister packs, jars & canisters, and overwrap.

Paper & paperboard is the second-largest material used in pharmaceutical packaging owing to its lightweight and low-cost properties. Mostly it is preferred for secondary and tertiary packaging. The paper & paperboard material is used to make cartons, shrink wraps, boxes, and cardboards.

By Product Type Analysis

Plastic Bottles Segment to Account for the Major Share during the Forecast Period

Based on type, the market is categorized into plastic bottles, caps & closures, pre-fillable inhalers, pre-fillable syringes, vials & ampoules, blister packs, bags & pouches, jars & canisters, cartridges, and others. Among these, the plastic bottles segment is the largest product type. The growth of this segment is attributed to the lightweight, easy to mold, and low-cost properties of plastic bottles. Additionally, plastic bottles have gained preference in the packaging of solid as well as liquid pharmaceutical preparations such as tablets, capsules, syrups, ophthalmic, and nasal medications. Increasing demand for plastic bottles in the pharmaceutical industry is expected to drive the market growth.

The pre-fillable syringes segment is anticipated to witness the fastest growth during the review period. These syringes are transparent, lightweight, ready-to-fill, break-resistant, and serve as an efficient replacement for traditional syringes. They also provide metered dosage without any wastage and enable self-administration. An increasing need for immediate treatment along with rising diseases such as diabetes and heart diseases are expected to surge the demand for pre-fillable syringes.

By Packaging Type Analysis

Primary Packaging Segment to be the Fastest-growing Packaging Type in the Market

Based on the packaging type, the market is classified into primary, secondary, and tertiary. Primary packaging is the largest and fastest-growing packaging type in this market. This packaging type directly comes in contact with the drug, hence has to meet all the regulatory parameters and maintain the quality of the drug. Plastic bottles, caps & closures, blister packs, pre-fillable inhalers, pouches, and medication tubes are some of the packaging products included in this packaging type. These products protect the drugs from moisture, chemicals, and aid in maintaining the shelf life of the drug.

Secondary packaging is used for packing a group of primary packaged products. This segment consists of boxes and cartons. This packaging provides detailed information about the drug, including ingredients, manufacturer’s name and address, precautions, and use and storage instructions, and helps to differentiate drugs from one another.

By Drug Delivery Mode Analysis

To know how our report can help streamline your business, Speak to Analyst

Oral Drug Delivery Packaging to Account for Dominant Share during the Forecast Period

Based on drug delivery mode, the market includes oral drug delivery packaging, injectable packaging, topical drug delivery packaging, pulmonary drug delivery packaging, transdermal drug delivery packaging, ocular drug delivery packaging, nasal drug delivery packaging, and others. The oral drug delivery packaging is the dominant segment in the market. Pharmaceutical preparations are majorly consumed orally in the form of tablets, capsules, powders, liquids, and semi-liquids. The flexibility in designing dosage and cost-effective production makes oral drug delivery an ideal choice, which further fuels the development of this segment.

The injectable packaging segment is the second-largest segment in the market. It covers a wide range of preparations from injection solutions to implants. The products such as prefilled syringes or auto-injector pens, vials, and ampoules are used in injectable packaging. Increasing use of injections for drug delivery will fuel the demand for injectable packaging.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a sample

The pharmaceutical packaging market size in North America stood at USD 26.89 billion in 2019.

Based on region, the market is categorized into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America holds the largest share in the global market. The U.S. is the largest contributor in this region. The growth in this region is on account of rapidly rising pharmaceutical industry. Moreover, rising demand for primary packaging products, increasing healthcare spending, and rising disease prevalence is further driving the market growth in this region.

Europe is the second-largest region in the pharmaceutical packaging market share, with Germany, UK, and Italy being the leading countries. The growth in this region is attributed to the rising use of pharmaceutical products such as plastic bottles & containers, vials & ampoules, and pre-fillable syringes. Further, rising adoption of new and stringent regulations by governments to control the spread of infectious diseases, including COVID-19, have propelled the lucrative growth of this market. In Asia-Pacific, China, Japan, and India are the leading countries contributing to the growth of the market. Rising investments and expansion of pharmaceutical manufacturing companies in these countries are expected to provide growth opportunities to the market in this region.

KEY INDUSTRY PLAYERS

Key Players to Use Organic and Inorganic Growth Strategies to Maintain Their Market Position                

At present, the competitive landscape of this market depicts a semi-consolidated market with the top 15 companies accounting for majority share in the market. Key players have invested a considerable amount of resources in research and development of several medical packaging products and technologies to produce them. A diversified product portfolio, superior operational efficiency, and safe & novel technological development for pharmaceutical packaging applications are the strategies used by the market leaders for their growth. The companies have also adopted the strategies of expansion, new product development, partnership, and acquisition with to increase their regional presence and strengthen their product portfolio.

LIST OF KEY Market COMPANIES PROFILED:

• Amcor Plc (Switzerland)


• Gerresheimer AG (Germany)


• Origin Pharma Packaging (UK)


• Nelipak Healthcare (Canada)


• Pharma Packaging Solutions (US)


• Schott AG (Germany)


• Becton Dickinson & Company (US)


• West Pharmaceutical Services, Inc. (US)


• WestRock (US)


• AptarGroup, Inc. (US)


• Berry Global, Inc. (US)


• NIPRO (Japan)


• Carcano Antonio S.p.A. (Italy)


• SABIC (Saudi Arabia)


• Lonza Group AG (Switzerland)


• ALPLA-Werke Alwin Lehner GmbH & Co KG (Austria)


• Constantia Flexibles (Austria)


• CCL Industries Inc. (Canada)


• Frank Noe Egypt Ltd (Egypt)


• Gaplast Gmbh (Germany)


• Others

KEY INDUSTRY DEVELOPMENTS:

• July 2019 – Berry Global Group, Inc. acquired RPC Group Plc (RPC), a leading producer of plastic packaging, for approximately US$ 6.5 billion. This acquisition will strengthen Berry’s knowledge in innovative material science, manufacturing technologies, and product development capability.


• March 2019 – SCHOTT developed EVERIC, a new generation of ultra-pure pharmaceutical vials for sensitive drugs and drugs with small filling volumes. These new vials will allow the company to serve its customers from the pharmaceutical industry to package their biologic drugs.

REPORT COVERAGE

The pharmaceutical packaging market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, materials used in packaging, sterilization method adopted, and leading applications of the product. Besides this, the report offers insights into the pharmaceutical packaging market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over recent years.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation